GPD1 Antikörper (N-Term)
Kurzübersicht für GPD1 Antikörper (N-Term) (ABIN453067)
Target
Alle GPD1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 35-65, N-Term
-
Spezifität
- This antibody detects GPD1 at N-term.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human, Mouse.
-
Aufreinigung
- Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 35~65 amino acids from the N-terminal region of Human GPD1
-
-
-
-
Applikationshinweise
-
Western blot: 1: 100 - 1: 500. ELISA: 1: 1,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- GPD1 (Glycerol-3-Phosphate Dehydrogenase 1 (Soluble) (GPD1))
-
Andere Bezeichnung
- GPD1
-
Hintergrund
- GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle.Synonyms: GPD-C, GPDC, GPDH-C, GPDHC, Glycerol-3-phosphate dehydrogenase, Glycerol-3-phosphate dehydrogenase [NAD+] cytoplasmic
-
Molekulargewicht
- 37568 Da
-
Gen-ID
- 2819
-
NCBI Accession
- NP_005267
-
UniProt
- P21695
Target
-